FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA has approved a supplemental application for glucagon submitted by Fresenius Kabi USA, LLC. The approval finalizes changes proposed in the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

SUPPL AP for GLUCAGON (GLUCAGON)